Toggle Side Panel
Close search

Pulmonary Hypertension News Community › Forums › PH Care and Treatment › Treatments and Therapies › PAH Therapy Livantra Gets FDA Orphan Drug Status

  • Treatments and Therapies

    PAH Therapy Livantra Gets FDA Orphan Drug Status

    Posted by Community Member on August 20, 2018 at 9:42 am

    The FDA granted orphan status to Livantra, a repurposed drug approved for another indication outside the U.S., for the treatment of PAH.

    Read more about this possible treatment option for PH here.

    What are your thoughts on this news?

    Community Member replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .